John is a senior scientist with more than 25 years of experience in drug discovery roles, developing biochemical and cellular assays in a range of technologies and formats, utilising an array of laboratory equipment and automation.
John has a degree from the University of Nottingham and previously worked for 23 years at AstraZeneca in roles spanning microbiology, oncology and high-throughput screening. In his role at the Medicines Discovery Catapult, John is responsible for the development and validation of robust cellular and biochemical in vitro assays to monitor target engagement and modulation and provides expertise in the areas of drug discovery, screening and automation.
